A detailed history of Prelude Capital Management, LLC transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 42,763 shares of CDMO stock, worth $534,109. This represents 0.04% of its overall portfolio holdings.

Number of Shares
42,763
Holding current value
$534,109
% of portfolio
0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$9.96 - $12.36 $425,919 - $528,550
42,763 New
42,763 $528,000
Q4 2020

Feb 16, 2021

SELL
$7.25 - $11.76 $2,900 - $4,704
-400 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$6.53 - $8.6 $2,612 - $3,440
400 New
400 $3,000
Q2 2019

Aug 14, 2019

SELL
$3.43 - $5.6 $5,903 - $9,637
-1,721 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$3.56 - $4.82 $6,126 - $8,295
1,721 New
1,721 $7,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $776M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.